Positive regulatory ramifications for CPH from US Marijuana Act
Finfeed
Archived
Dec 07, 2020
Creso Pharma Limited (ASX: CPH; FRA: 1X8) has advised that the US House of Representatives has passed the Marijuana Opportunity Reinvestment and Expungement (MORE) Act to remove cannabis for the US Controlled Substances Act.
